Skip to Main Content

Paper Details

Abnormal liver tests are not sufficient for diagnosis of hepatic graft-versus-host disease in critically ill patients.
Hepatol Commun
1
2022
GVHD, HGVHD, Hepatic graft-versus-host disease, bilirubin, cholestatic, cholestatic injury, critically, hematopoietic stem cell, hepatic graft-versus-host disease, liver injury, patients
Author NameAffiliation
Christopher KohLiver Diseases BranchNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)BethesdaMarylandUSA.
Christopher KohLiver Diseases BranchNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)BethesdaMarylandUSA.
Steven Z PavleticImmune Deficiency Cellular Therapy ProgramNational Cancer Institute (NCI)BethesdaMarylandUSA.
Steven Z PavleticImmune Deficiency Cellular Therapy ProgramNational Cancer Institute (NCI)BethesdaMarylandUSA.
Theo HellerLiver Diseases BranchNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)BethesdaMarylandUSA.
Theo HellerLiver Diseases BranchNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)BethesdaMarylandUSA.
  • 1 - 6

Datasets

Release 1.2